TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Cancer Vaccines Launch Pad

Health services
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "Cancer Vaccines Launch Pad". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
66.2Bids / Report
11.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 515 active published awards; 512 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published29 Feb 2024, 16:58 GMT
Last source update29 Feb 2024, 16:58 GMT
Recurring procurementNot published
ClassificationHealth services
Delivery area
UK
OCIDocds-h6vhtk-040e7a
What is being bought
The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), the National Institute of Health Research (NIHR) and Genomics England (GEL), with the aim to facilitate access to personalised cancer vaccine research trials. The project was jointly announced in July 2023 with the Secretary of State and in partnership with the Prime Minister. See link (https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials#:~:text=It%20will%20work%20by%20creating,become%20part%20of%20standard%20care)<br/><br/>Through the CVLP platform, cancer patients from across a network of up to 140 NHS cancer care providers will be asked to consent to be put forward for clinical trials. Their surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility. The detail of any available trials will be shared with the participant and their treating clinical team to see if the patient wishes to take part, and if so, the patient will travel to the nearest trial site to access the clinical trial.
What changed
From the official release history
  1. tender value changed
    29 Feb 2024, 16:58 GMT
  2. Status changed to complete
    29 Feb 2024, 16:58 GMT
  3. Official notice release published
    29 Feb 2024, 16:58 GMT
  4. Submission deadline changed to published date
    29 Feb 2024, 16:58 GMT
  5. Published value updated to £2,100,000
    24 Oct 2023, 10:49 BST
  6. Status changed to active
    24 Oct 2023, 10:49 BST
  7. Official notice release published
    24 Oct 2023, 10:49 BST
  8. Submission deadline changed to 24 Nov 2023, 00:00 GMT
    24 Oct 2023, 10:49 BST
  9. Buyer information updated
    24 Oct 2023, 10:49 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The CVLP is a feasibility study, facilitating access to personalised treatment cancer trials, for example cancer vaccines. Patients will be identified across a network of up to 140 NHS cancer care providers. Patients in the CVLP will be asked to consent for analysis of their tumour material, peripheral blood (if trial requires), and clinical data to establish whether they might be suitable for current or future cancer vaccine trials. The detail of any available trials will be shared with the participant and their treating clinical team, to see if they would consider taking part in the trial(s) for which they are eligible.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    29 Feb 2024, 16:58 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 12 Feb 2024, 00:00 GMT · £1,397,952
Commercial outcome and competition
Awards
UNIVERSITY OF SOUTHAMPTON
Not published · Not published · active
Contracts
Contract
£1,397,952 · signed 12 Feb 2024, 00:00 GMT · active
Bid statistics
bids: 4 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-67205
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published